Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-03-01 Option Award | 2022-03-02 4:10 pm | N/A 2032-03-01 | Checkmate Pharmaceuticals Inc. | CMPI | BASH ALAN Chief Executive Officer | 575,000 | $0 | 575,000 (Direct) | View |
| 2022-01-30 Option Award | 2022-02-01 4:25 pm | N/A 2032-01-29 | Checkmate Pharmaceuticals Inc. | CMPI | Wigginton Jon Marc Director | 20,061 | $0 | 20,061 (Direct) | View |
| 2022-01-27 Option Award | 2022-01-31 4:05 pm | N/A 2032-01-26 | Checkmate Pharmaceuticals Inc. | CMPI | Dolski Robert Chief Financial Officer | 101,180 | $0 | 101,180 (Direct) | View |
| 2022-01-27 Option Award | 2022-01-31 4:05 pm | N/A 2032-01-26 | Checkmate Pharmaceuticals Inc. | CMPI | Wooldridge James Chief Medical Officer | 101,180 | $0 | 101,180 (Direct) | View |
| 2021-12-16 Option Award | 2021-12-17 8:22 pm | N/A 2031-12-16 | Checkmate Pharmaceuticals Inc. | CMPI | Yan Joy Director | 20,061 | $0 | 20,061 (Direct) | View |
| 2021-10-27 Option Award | 2021-10-29 6:54 pm | N/A 2031-10-27 | Checkmate Pharmaceuticals Inc. | CMPI | Fuhrman Alan See Remarks | 246,671 | $0 | 246,671 (Direct) | View |
| 2021-08-09 Option Award | 2021-08-10 4:05 pm | N/A 2031-08-09 | Checkmate Pharmaceuticals Inc. | CMPI | POWELL MICHAEL Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2021-08-04 Option Award | 2021-08-06 4:05 pm | N/A 2031-08-03 | Checkmate Pharmaceuticals Inc. | CMPI | Dolski Robert Chief Financial Officer | 27,300 | $0 | 27,300 (Direct) | View |
| 2021-08-04 Option Award | 2021-08-06 4:05 pm | N/A 2031-08-03 | Checkmate Pharmaceuticals Inc. | CMPI | Chaudhary Kleem Chief Business Officer | 27,300 | $0 | 27,300 (Direct) | View |
| 2021-08-04 Option Award | 2021-08-06 4:05 pm | N/A 2031-08-03 | Checkmate Pharmaceuticals Inc. | CMPI | Wooldridge James Chief Medical Officer | 27,300 | $0 | 27,300 (Direct) | View |
| 2021-08-04 Option Award | 2021-08-06 4:05 pm | N/A 2031-08-03 | Checkmate Pharmaceuticals Inc. | CMPI | Labinger Barry President and CEO | 85,950 | $0 | 85,950 (Direct) | View |